The immunopathology of Alzheimer's disease and some related disorders (Q40807293)

23 September 2017

1 reference

title

The immunopathology of Alzheimer's disease and some related disorders (English)

1 reference

23 September 2017

0 references

Kalaria RN

1

1 reference

23 September 2017

publication date

1 October 1993

1 reference

23 September 2017

1 reference

23 September 2017

volume

3

1 reference

23 September 2017

issue

4

1 reference

23 September 2017

page(s)

333-347

1 reference

Complement proteins and complement inhibitors in Alzheimer's disease

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Neuroimmunology of Alzheimer's disease: a conference report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Humoral and cellular immunologic repertoire in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Immuno-electron microscopic localization of immunoglobulins in amyloid fibrils of senile plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Activation of the classical complement pathway in brain tissue of Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Complement mRNA in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Complement gene expression in human brain: comparison between normal and Alzheimer disease cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Complement activation by beta-amyloid in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Serum amyloid p and related molecules associated with the acute-phase response in alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

A Monoclonal Antibody That Reacts Immunohistochemically with Amyloid Deposits in the Brain Tissue of Alzheimer Patients Binds to an Epitope Present on Complement Factor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Structural and functional relationships among receptors and regulators of the complement system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Synthetic Alzheimer amyloid beta/A4 peptides enhance production of complement C3 component by cultured microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Complement allotypes in familial and sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Distribution of clusterin in Alzheimer brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Immunohistochemical localization of vitronectin, its receptor and beta-3 integrin in Alzheimer brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

SP-40,40 is a constituent of Alzheimer's amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Complement inhibitor C4-binding protein in amyloid deposits containing serum amyloid P in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Complement activation and beta-amyloid-mediated neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Immunodetection of the amyloid P component in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

α2-macroglobulin and subacute-phase responses in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Alpha 2-macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells Potential significance for the processing of Alzheimer β-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

The molecular pathology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Thrombin accumulation in brains of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

IL-6-mediated events in Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Interleukin-1 stimulates the beta-amyloid precursor protein promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Transforming growth factor beta 1 regulates production of acute-phase proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Adhesion receptors of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Expression of intercellular adhesion molecule (ICAM)-1 by a subset of astrocytes in Alzheimer disease and some other degenerative neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Brain microglia constitutively express beta-2 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Epidermal growth factor receptor expression in demented and aged human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Ameboid microglia as effectors of inflammation in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease. 2. Non-neoplastic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

MHC class II-positive microglia in human brain: association with Alzheimer lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Microglia are associated with the extracellular neurofibrillary tangles of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Acute phase proteins but not activated microglial cells are present in parenchymal beta/A4 deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Bone marrow derived elements and resident microglia in brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

A case for chaperones in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Antigen presentation by brain microvessel smooth muscle and endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Expression of the histocompatibility glycoprotein HLA-DR in neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Immune system associated antigens expressed by cells of the human central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Senile plaques as aberrant sprout-stimulating structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Antibodies in cerebrospinal fluid of some Alzheimer disease patients recognize cholinergic neurons in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Antibodies in the cerebrospinal fluid of some Alzheimer's disease patients recognize amoeboid microglial cells in the developing rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Antibodies to cholinergic neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Anti-neuronal antibodies similar to those found in Alzheimer's disease induce memory dysfunction in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Antibodies from Down's syndrome patients bind to the same cholinergic neurofilament protein recognized by Alzheimer's disease antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Detection of brain autoantibodies in the serum of patients with Alzheimer's disease but not Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Antibodies to viral antigens, xenoantigens, and autoantigens in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Elevated circulating tumor necrosis factor levels in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Senile dementia of Alzheimer's type (SDAT): reduced T8+-cell-mediated suppressor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

The decrease of CD8-positive lymphocytes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Elevation of human cerebrospinal fluid clusterin concentration is associated with acute neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Immunological indices in presenile Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Human astrocytes express membrane cofactor protein (CD46), a regulator of complement activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1993.TB00761.X

10.1111/J.1750-3639.1993.TB00761.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference